Clinical effectiveness of immune therapies of solid tumors requires a) the induction or expansion of T cells able of recognizing multiple variants of cancer cells present in each cancer patient, and b ...
Hosted on MSN
Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines
A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA cancer vaccine platform. The study introduces an immune cell homing ...
From mutation to medicine: How neoantigen dendritic cell vaccines are reshaping cancer immunotherapy
Overview of the manufacturing process of personalized neoantigen-based DC vaccines. A typical basic process of manufacturing neoantigen-based DC vaccines by using monocyte-derived dendritic cells is ...
Patients with intermediate stage primary liver cancer who received a vaccine of dendritic cells saw a longer time without tumour progression in response to standard treatment according to a new study ...
Treating the brain cancer glioblastoma (GBM) demands more than conventional strategies due to a mix of factors including the cancer’s genetic complexity, invasive growth, and immune resistance. A new ...
8don MSN
Intranasal vaccine booster shows stronger immune response and protection against sarbecoviruses
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash University in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results